Cargando…
Epigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer
Similar to genetic alterations, epigenetic aberrations contribute significantly to tumor initiation and progression. In many cases, these changes are caused by activation or inactivation of the regulators that maintain epigenetic states. Here we review our current knowledge on the KDM5/JARID1 family...
Autores principales: | Blair, Lauren P., Cao, Jian, Zou, Mike Ran, Sayegh, Joyce, Yan, Qin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085456/ https://www.ncbi.nlm.nih.gov/pubmed/21544224 http://dx.doi.org/10.3390/cancers3011383 |
Ejemplares similares
-
KDM5 lysine demethylases are involved in maintenance of 3′UTR length
por: Blair, Lauren P., et al.
Publicado: (2016) -
The Lysine Demethylase KDM5B Regulates Islet Function and Glucose Homeostasis
por: Backe, Marie Balslev, et al.
Publicado: (2019) -
Histone Lysine Demethylases KDM5B and KDM5C Modulate Genome Activation and Stability in Porcine Embryos
por: Glanzner, Werner Giehl, et al.
Publicado: (2020) -
Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC
por: Wei, Yongyue, et al.
Publicado: (2018) -
The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer
por: Metzler, Veronika M., et al.
Publicado: (2023)